KLK8 and early-onset autosomal dominant Alzheimer disease: Recently, KLK8 inhibition was proposed as therapeutic target in Alzheimer’s disease, which is accompanied by elevated KLK8 protein levels, while in a murine Alzheimer’s model Klk8 inhibition by antibodies significantly attenuated the pathology45.